Pro Dex (PDEX) EBITDA (2010 - 2026)

Pro Dex has disclosed EBITDA across 14 years of filings, most recently posting $3.1 million for Q1 2026.

• EBITDA for Q1 2026 came in at $3.1 million, down 15.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $10.8 million (down 7.61% YoY), and the FY2025 annual result was $10.7 million, up 49.02% from the prior year.
• EBITDA came in at $3.1 million for Q1 2026 at Pro Dex, down from $3.3 million in the prior quarter.
• In the past five years, EBITDA ranged from a high of $3.6 million in Q1 2025 to a low of $777000.0 in Q4 2023.
• The 5-year median for EBITDA is $2.1 million (2023), against an average of $2.1 million.
• Across the five-year window, EBITDA plunged 45.25% in 2022 and surged 246.46% in 2024, its largest moves.
• Pro Dex's EBITDA stood at $1.1 million in 2022, then plunged by 31.66% to $777000.0 in 2023, then soared by 246.46% to $2.7 million in 2024, then advanced by 21.06% to $3.3 million in 2025, then slipped by 5.06% to $3.1 million in 2026.
• The last three EBITDA figures came in at $3.1 million (Q1 2026), $3.3 million (Q4 2025), and $3.1 million (Q3 2025), per Business Quant data.